<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: The diagnosis and quantification of <z:e sem="disease" ids="C0155765" disease_type="Disease or Syndrome" abbrv="">microangiopathy</z:e> in <z:hpo ids='HP_0000726'>dementia</z:hpo> is difficult </plain></SENT>
<SENT sid="1" pm="."><plain>The assessment of small-vessel disease requires expensive and sophisticated nuclear medicine techniques </plain></SENT>
<SENT sid="2" pm="."><plain>This study was performed to identify <z:e sem="disease" ids="C0155765" disease_type="Disease or Syndrome" abbrv="">microangiopathy</z:e> related to the integrity of cerebral microcirculation by sonographic measurements (arteriovenous cerebral transit time [cTT]) </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We performed transcranial color-coded duplex sonography in 40 patients with vascular <z:hpo ids='HP_0000726'>dementia</z:hpo>, 20 patients with <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> or <z:e sem="disease" ids="C0752347" disease_type="Disease or Syndrome" abbrv="DLB">Lewy body disease</z:e>, and 25 age-matched controls </plain></SENT>
<SENT sid="4" pm="."><plain>The clinical diagnosis was established by history of <z:hpo ids='HP_0000726'>dementia</z:hpo> and neuroimaging findings </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0100543'>Cognitive impairment</z:hpo> was assessed by the Mini-Mental State Examination and <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's Disease</z:e> Assessment Scale </plain></SENT>
<SENT sid="6" pm="."><plain>cTT is defined as the time required by an ultrasound contrast agent to pass from a cerebral artery to a vein </plain></SENT>
<SENT sid="7" pm="."><plain>This was measured by recording the power-Doppler intensity curves in the P2 segment of the posterior cerebral artery and the vein of Galen </plain></SENT>
<SENT sid="8" pm="."><plain>Previous studies have shown a prolongation of cTT in patients with cerebral <z:e sem="disease" ids="C0155765" disease_type="Disease or Syndrome" abbrv="">microangiopathy</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>RESULTS: cTT was substantially prolonged in patients with vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (5.8 seconds; 25th percentile 4.5; 75th percentile 7.5; U test, P&lt;0.001) compared with controls (3.1 seconds; 2.3; 3.4) but not in patients with degenerative <z:hpo ids='HP_0000726'>dementia</z:hpo> (3.7 seconds; 3.7; 4.2) </plain></SENT>
<SENT sid="10" pm="."><plain>In patients with vascular <z:hpo ids='HP_0000726'>dementia</z:hpo>, cTT was significantly correlated with <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: cTT may be useful tool to disclose small-vessel disease in <z:e sem="disease" ids="C0860630" disease_type="Mental or Behavioral Dysfunction" abbrv="">demented</z:e> patients </plain></SENT>
<SENT sid="12" pm="."><plain>Examination is noninvasive and quickly performed </plain></SENT>
<SENT sid="13" pm="."><plain>It may be also useful in follow-up examinations in patients undergoing therapy </plain></SENT>
</text></document>